Monopar Therapeutics (MNPR) Tops Q1 EPS by 38c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of $0.38.
For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Boeing names Ryan Shedd as new SVP and controller
- QSE closes $6M private placement with final tranche of $674K
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
